addition, patients with one or no abnormal autonomic function tests had a mean fibrinogen of proteinuria ( 3.3 g / day: range 0.3 to 8.9 ) and azotemia ( creatinine clearance: 58 mL /min, range less than 400 mg / dL compared to the group of patients with two or more abnormal tests who had 30 to 112 ) were tested for 24-h mean arterial blood pressure; instantaneous heart rate variations to a a mean fibrinogen of 500 mg / dL. In patients with demonstrated parasympathetic abnormalities, computerized protocol involving timed ventilation, assumption of upright posture, and postural heart rate variation testing also discerned a differential in plasma fibrinogen. Lower Valsalva maneuver ; plasma fibrinogen, viscosity, fibrinolytic activity, and plasminogen activator concentration of plasminogen activator inhibitor throughout the day, and greater fibrinolytic inhibitor. These were to test the hypothesis that autonomic dysfunction is associated with altered activity in the morning were also noted to be present in patients with abnormal heart rate concentrations of plasma fibrinogen, fibrinolytic activity, viscosity, and plasminogen activator response to the Valsalva maneuver. We conclude that there are relationships between high blood inhibitor. We have previously shown the absence of a correlation between level of blood pressure, pressure, autonomic function, and hemostatic factors favoring thrombogenesis that may be clinical and standard laboratory testing, and the results of the autonomic function testing protocol related by common mechanisms and treatments in the diabetic with kidney disease. ᭧ 1997 used in this study. In this group of patients, plasma fibrinogen concentration was correlated American Journal of Hypertension, Ltd. Am J Hypertens 1997; 10:454 -461 ( positively ) with mean arterial pressure and ( negatively ) with heart rate variation in response to the Valsalva maneuver. The greater the mean arterial pressure or the worse the Valsalva results, KEY WORDS: Insulin-dependent diabetes mellitus, autonomic function, plasma fibrinogen. the higher the plasma fibrinogen concentration. In
A HYPOTHESIS Accelerated atherosclerosis with an increased incidence of cardiovascular events is because of increased n increased rate of myocardial infarctions in the morning hours has been explained by increased sympathetic nervous system function upon arising, leading to more concentrations of procoagulants, of cholesterol related rapid heart rate, higher systemic blood pressure, and lipids, and perhaps of other blood constituents ( admore rapid platelet aggregation. Decreased parasymvanced glycosylated end-products, homocysteine ) pathetic stimulation has been associated with a that may increase blood viscosity or change blood rhegreater number of sudden deaths because of ventricuology. Conditions in which atherosclerosis and carlar arrhythmias. 1 -4 In type I diabetes mellitus paradiovascular event rate have been shown to be insympathetic dysfunction often precedes clinical neucreased are often associated with autonomic dysfuncropathic symptoms. 5, 6 It follows that abnormal circation ( sudden death after myocardial infarction ) . We dian variation of blood pressure control proceeds postulate that there is an interrelationship between directly from altered autonomic function in diabetics.
altered autonomic control of cardiovascular tone (paraWe have recently begun to document aspects of diasympathetic defect/sympathetic dominance) and the betic peripheral and autonomic neuropathy to correconcentration of some blood constituents responsible late these with standard risk factors for cardiovascular for increased cardiovascular events in diabetics with complications. At baseline there appears to be no stanephrotic syndrome. tistically significant relationship between standard risk factors for macrovascular disease and the severity MATERIALS AND METHODS of diabetic autonomic dysfunction, even when age, duration of diabetes, and level of renal dysfunction We studied 23 insulin-dependent juvenile onset diabetics ( 16 men, 7 women ) between the ages of 21 and are taken into account. 7 To date there have been no reports evaluating relationships between dysfunc-65 years ( mean age 39.5 years ) who had: 1. onset of insulin dependence before the age of 35; 2. albumintions observed in the autonomic nervous system of diabetics and a full panel of fibrinolytic / procoagulant uria ú 0.1 g / day or proteinuria ú 0.3 gm/ day on two separate 24-h urine collections; 3. creatinine clearblood tests now available on a research basis.
The interface between atherosclerotic plaque dis-ance of more than 30 mL /min; 4. ability to be followed for a period of 18 months at the Joslin Clinic; 5. willruption, concentrations of lipids, generation or lysis of fibrin, and the activity of the sympathoadrenal system ingness to accept randomization; and 6. absence of pregnancy or an acute or chronic illness that would during early morning hours has been the focus of much clinical research. The majority of studies have render testing uninterpretable ( drug dependence, active hepatitis, recent myocardial infarction, or stroke, focused on large groups of patients at low risk for cardiovascular events, or on postmortem data. The etc.) . These diabetics were prospectively and consecutively enrolled as part of a multicenter study involvstudy of a group of patients at high risk for such events may provide useful information regarding trig-ing seven institutions in the United States. Using an 18-month follow-up period, comparisons of a regimen ger mechanisms. The variable timing of atherosclerotic events ( myocardial infarction, sudden death, including 3 to 4 injections of insulin per day were made with a similar regimen in which a weekly infuand stroke ) has been the subject of theories regarding the mechanisms that trigger them. 8, 9 There appears to sion of intravenous insulin was added. 21 Enrollment in this study required a workup of several weeks to be a circadian distribution of ischemic events, along with some of the markers of risk suggesting relation-collect the required urine samples and confirm the adequacy of control of diabetes mellitus and blood ships between autonomic nervous system function and variations in blood pressure, heart rate, and blood pressure. To have interpretable data, we attempted to avoid use of any drug that was, at the time, known markers for coagulation / fibrinolysis. In vitro and in vivo testing has suggested that the morning peak in to exert major effects on the autonomic nervous system that would interfere with either the patient's senmyocardial events may be blunted by b-adrenergic blockade.
10 -12 The blunting of heart rate increase in sation of hypoglycemic reactions or with the testing of cardiac autonomic function. The patients at the Joslin the morning and of pressor response upon awakening have usually but not always been sufficient to explain Clinic underwent cardiac autonomic function tests that included computerized measurements of heart the beneficial effect of b-adrenergic blockade.
13,14 bBlockers decrease the risk of plaque rupture because rate variation ( NDX, q Med Inc., Lawrence Harbor, NJ ) during a period of timed ventilation, standardflexability and tensile strength of the fibrous cap are increased when heart rate is diminished. 15 Once mi-ized Valsalva maneuver ( expiration against a 40 mm Hg mercury column ) , recumbent to a standing posicroangiopathy is present ( renal ) , a large percentage of diabetics will have coronary arterial disease that is tion change, and 24-h ambulatory blood pressure measurements ( 90207 SpaceLabs, Redmond, WA ) . In asymptomatic.
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/ 2e15$$2179 03-10-97 11:49:42 eajha EL: AJH addition to the autonomic studies, each patient under-mm Hg ( daytime MAP 100.4 mm Hg, nighttime MAP 98.1 mm Hg ) . Glycohemoglobin A 1C mean was 9.5% went a standardized phlebotomy at 8 AM and 4 PM at baseline and at 3-month intervals for plasma fibrino-( range 6.4 to 11.8 ) , hematocrit mean 40% ( range 31 to gen, plasma viscosity, plasminogen activator inhibitor 53 ) , serum albumin mean 3.7 g / dL ( range 3.0 to 4.5 ) , antigen, factor 7, von Willebrand factor, fibrinolytic serum cholesterol mean 232 mg / dL ( range 122 to 402 ) , activity, and aggregation response of platelets to ADP, HDL cholesterol 51 mg / dL ( range 32 to 82 ) , triglycerepinephrine, and collagenase.
ide 151 mg / dL ( range 44 to 489 ) , serum uric acid 5.8 For this study, to avoid questions of mixing normals mg / dL ( range 4.6 to 8.4 ) , serum creatinine 1.8 mg / into our abnormal group, we have strictly defined dL ( range 1.0 to 3.6 ) , creatinine clearance 58 mL /min heart rate variations ( HRV ) as abnormal only if timed ( range 30 to 112 ) , and urine albumin 3.3 g / 24 h ( range ventilation caused õ 10% variation ( heart rate ratio õ 0.3 to 8.9 ) . 1.09 ) , Valsalva response resulted in õ 20% variation There were no significant correlations between any ( heart rate ratio õ 1.19 ) , or if postural change õ 5% of the above and any of the four autonomic function ( heart rate ratio õ 1.04 ) was observed. These numbers tests described individually or by groupings. are clearly abnormal for all ages included in this Coagulation Tests Mean plasma fibrinogen was 424 study. The day / night blood pressure ratio was conmg / dL ( range 238 to 711 ) , mean plasma viscosity 1.24 sidered to be abnormal if there was õ 5% variation.
centipoise ( range 1.10 to 1.43 ) , fibrinolytic activity was For purposes of this study we defined day blood pres-166.3 mm 2 ( range 60 to 264 ) , and plasminogen activator sures as those occurring in the 16 h from 8 AM to inhibitor was 7.41 ng /mL ( range 2.4 to 30.9 ) . A signifimidnight, and night blood pressures as those recant positive correlation between plasma fibrinogen corded in the 8 h from midnight to 8 AM . To further and mean arterial pressure for 24 h was noted ( Figure classify autonomic function results we defined several 1 ) . Plasma viscosity had a significant positive correladifferent classifications of autonomic dysfunction: ie, tion with both glycohemoglobin and plasma fibrinogen, by a ) individual test abnormalities; b ) number of tests although there appeared to be no statistically significant abnormal ( 0 to 1 v 3 to 4 ) ; c ) selective sympathetic relationship between glycohemoglobin and serum fitesting in patients whose parasympathetic tests were brinogen. In Figure 2 there is a significant negative corabnormal ( n Å 17 ) by the criteria so stated; and d ) relation between plasma fibrinogen concentration and creating groups of parasympathetic test dysfunction heart rate variation during the Valsalva maneuver ( ie, ( timed ventilation HRV or Valsalva HRV abnormalithe more abnormal the Valsalva result, the higher the ties ) versus sympathetic dysfunction ( postural HRV plasma fibrinogen ) . In both figures plasma fibrinogen or day / night mean arterial pressure variation abnorlevels ( 220 to 780 mg / dL ) were distributed above 300 malities ) . Hemoglobin A 1C ( high pressure liquid chromatography, Nichols Institute, Van Nuys, CA ) was considered high if ú 9.0% for purposes of this study.
Frequency data were tested for significance using x 2 for independence following the implementation of Yates correction for continuity. In cases where expected frequencies õ 5, Fisher's exact test was used. For quantitative variables, unpaired t tests were used to test for significance between the means of various classification variables ( gender, normal-abnormal stratification of cardiac autonomic function ) . Because, in some cases, stratification groups differed significantly in mean age, the same variables were compared using analyses of covariance with age as the covariant.
Interrelationships among the variables were tested for significance using Pearson's Product Moment correlations. All data are expressed as frequencies or means with standard deviations as a measure of dispersion. An a Å 0.05 was considered statistically significant. All analyses were carried out using SAS software ( SAS Institute, Cary, NC ) . In patients with parasympathetic dysfunction, sympathetic testing included both assumption of upright posture HRV and day / night MAP variation. In Figure  5 plasma fibrinogen concentrations were similar throughout the day in both the abnormal and normal postural HRV groups. Plasma fibrinogen concentrations were higher for the abnormal postural HRV group ( P õ .05 for the PM only ) compared to the normal postural HRV group. Day / night MAP variation again did not correlate with plasma fibrinogen level.
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RESULTS
FIGURE 1. Relationship of 24-h mean arterial blood pressure
Demographics
For the purposes of comparison, creating groups of pure parasympathetic versus pure sympathetic dysfunction led to groups that were too small to make meaningful comparisons. Treated hypertensive diabetics in this study had a high prevalence of abnormal autonomic function tests. 7 There appeared to be a relationship between mg / dL in 12 of the 14 study patients. No other signifi-asymptomatic autonomic dysfunction and the concencant positive or negative correlation between heart rate trations of intravascular blood constituents thought variation and either plasma fibrinogen, viscosity, ele-to be related to thromboembolic events. We observed ments of fibrinolytic activity, or mean arterial pressure a correlation between abnormal heart rate variation were noted.
test results, and plasma fibrinogen concentration. It is unlikely that this is a result merely of hemoconcentraAutonomic Function Testing Individual test abnormalities were noted in timed respiratory heart rate vari-tion or vasoconstrictor tone induced by the unopposed sympathetic system. Individuals with neation ( HRV ) in 17 / 21 patients, assumption of upright posture HRV in 7 / 20, Valsalva maneuver HRV in 9 / phrotic syndrome from any cause may be expected to have an increased concentration of plasma fibrinogen, 15, and in day / night MAP in 14 / 21. Figure 3 relates plasma fibrinogen concentrations ( panel A ) , plasma but, to our knowledge, there have been no studies correlating the degree of both hyperfibrinogenemia fibrinolytic activity ( panel B ) , and plasma plasminogen activator inhibitor concentration ( panel C ) to Valsalva and increased blood viscosity with autonomic nervous control. The mechanism for hyperlipidemia and HRV ( normal v abnormal ) . In panel A, elevated plasma fibrinogen concentrations were not different for indi-hyperfibrinogenemia in nephrotic syndrome may hinge on hepatic synthesis of multiple proteins ( albuviduals with normal Valsalva HRV in AM versus PM or for individuals with abnormal Valsalva HRV in AM min, fibrinogen, and lipoprotein ) in response to hypoalbuminemia with hypoviscosity. We have no inforversus PM . Plasma fibrinogen concentrations were higher for individuals with abnormal Valsalva HRV (P mation testing the possibility that the autonomic nervous system contributes directly to the mechanism õ .05 for both AM and PM ) . In panel B, mean plasma fibrinolytic activity was within the normal range for responsible for hyperlipidemia / hyperfibrinogenemia in the nephrotic syndrome. We hypothesized that diaindividuals with both normal and abnormal Valsalva HRV. In both normal and abnormal Valsalva HRV betics with both severe autonomic dysfunction and significantly elevated plasma fibrinogen concentraplasma fibrinolytic activities were higher in the PM than in the AM . Plasma fibrinolytic activity was significantly tions were at the highest risk for thromboembolic events when compared with individuals demonstrahigher in the AM for individuals with abnormal Valsalva HRV compared to normal Valsalva HRV. In panel ting only one of these abnormalities.
Study patients who were capable of maintaining a C, plasma plasminogen activator inhibitor concentrations for individuals with abnormal Valsalva HRV were Valsalva maneuver with relatively normal results had lower ( morning and afternoon ) plasma fibrinogen significantly lower than those for individuals with normal Valsalva HRV ( P õ .05 for both AM and PM ) . parts whose Valsalva results were markedly abnor-and thrombolytic activity, as well as a relationship between loss of heart rate variation to the Valsalva mal. Patients whose Valsalva HRV results were markedly abnormal had significantly increased plasma maneuver and abnormal prothrombotic and thrombolytic activity. It is possible that patients who do not fibrinogen and increased fibrinolytic activity with decreased concentration of plasminogen activator inhib-vary their heart rates with the increase of intrathoracic pressure engendered by the Valsalva maneuver are itor. In this patient cohort there was a relationship between an intact heart rate response to Valsalva ma-demonstrating a highly stimulated sympathetic system. These patients may be at relatively higher risks neuver and normal control of intrinsic prothrombotic / 2e15$$2179 03-10-97 11:49:42 eajha EL: AJH resulting from hyperfibrinogenemia. In the hypertensive diabetic, loss of parasympathetic innervation leads to vasoconstriction and platelet aggregation. The hyperlipidemia associated with proteinuria contributes to plaque formation. Plaque rupture is most likely potentiated by unopposed sympathetic nerve stimulation. Beta blocker therapy may be justified despite the risks of hypoglycemia to prevent plaque rupture. A new antagonist of endothelin-A receptor will be of immediate use when available. 29 We have observed relationships between injury to the autonomic nervous system and changes in the common pathway of blood coagulation indicating a clustering of risk factors in the azotemic diabetic. Specifically, higher plasma fibrinogen levels were distributed among the group of patients whose Valsalva tests were more abnormal. Improved glucose control has been shown to improve elevated fibrinogen levels over several weeks of intensive insulin therapy. 30 Increased plasma fibrinogen contributes to more vigorous platelet aggregation. Increased plasma fibrinogen els may diminish small blood vessel occlusions. Although elevated levels of plasminogen activator inhibitor in the plasma are associated with an increased for cardiovascular events than those patients whose sympathetic tone is less active, and may benefit from risk of recurrent myocardial infarction, 32 there has been no correlation of risk for initial or subsequent efforts to reduce sympathetic stimulation. Follow-up studies will be necessary to elucidate the cardiovascular thromboembolic event rates in these subgroups.
Mechanisms for diabetic neuropathy are thought to involve ischemia resulting from low flow in the vasa vasora because of a ) increased plasma viscosity; b ) increased blood clotting; c ) impaired red blood cell and platelet flexibility leading to slow capillary flow 23 ; d ) hypoxia in tissues that require high flow in capillaries because of an impaired release of oxygen from glycosylated hemoglobin; e ) capillary injury at points of binding of advanced glycosylated end-products to their receptors leading to platelet adhesion 24 ; and f ) increased release of endothelin and von Willebrand factor from endothelium in diabetics with small vessel complications. 25, 26 The severity of vessel wall injury and the prothrombotic milieu within both the vessel and the circulating plasma determine the rapidity and severity of thrombosis. 27 Once the vessel has been injured the potent vasoconstrictor endothelin is released. The presence of thrombin further accelerates the release of endothelin, which induces chemotaxis, promotes replication of fibroblasts, accelerates contraction of collagen FIGURE 5. Relationship between HRV on assumption of upfibroblasts, and acts as a stimulator of microvascular right posture and plasma fibrinogen in patients with evidence platelet thrombi. 28 
